Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Makki Pharmaceutical Industries (MPI) is a leading private pharmaceutical manufacturer based in Damascus, Syria. Founded in 1994, the company focuses on the production of high-quality generic medicines across a diverse range of therapeutic areas, including cardiology, gastroenterology, and infectious diseases. MPI operates advanced manufacturing facilities in the Adra Industrial City, which are designed to meet international Good Manufacturing Practice (GMP) standards. The company's extensive product portfolio comprises over 150 formulations, including oral solids, liquids, and semi-solids. MPI plays a critical role in the Syrian healthcare sector by providing affordable essential medicines and also exports its products to several regional markets. The firm remains committed to expanding its technical capabilities and enhancing its product range to meet evolving medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Makki Pharmaceutical.